Scientists test stronger HIV prevention for expectant mothers
NCT ID NCT06435026
Summary
This study aimed to find the safest and most effective daily pill dose to prevent HIV in pregnant women in Africa. Researchers tested three different strengths of the prevention medication in 54 pregnant women to see how their bodies processed the drug and to check for safety. The goal is to protect both mothers and their babies from HIV infection during pregnancy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bwaila District Hospital
Lilongwe, Malawi
-
Seke North CRS
Harare, Zimbabwe
Conditions
Explore the condition pages connected to this study.